Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Oncology·MeSH: Carcinoma, Non-Small-Cell Lung

8 drugs in development·3 companies·3 clinical trials

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
Erlotinib	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 2(2)

Drug	Company
Crizotinib	Amneal Pharmaceuticals, Inc. (AMRX)
Pemetrexed	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 1(1)

Drug	Company
Crizotinib	ENANTA PHARMACEUTICALS INC (ENTA)

N/A(4)

Drug	Company
Crizotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Erlotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Pemetrexed Disodium	Crinetics Pharmaceuticals, Inc. (CRNX)
Pemetrexed Disodium	Amneal Pharmaceuticals, Inc. (AMRX)

BioSniper tracks 8 drugs in development for Stage IB Lung Non-Small Cell Carcinoma AJCC v7 across 3 companies.

There are 3 clinical trials targeting Stage IB Lung Non-Small Cell Carcinoma AJCC v7 tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.